Kaliumchloride - Glucose B. Braun

Potassium chloride, the active ingredient in Kaliumchloride - Glucose B. Braun, is an electrolyte solution presented as an intravenous solution for intravenous use. It treats hypokalemia and provides glucose for energy supplementation in patients requiring electrolyte and fluid replenishment.

GNH USA supplies Kaliumchloride - Glucose B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchloride - Glucose B. Braun is used in clinical situations that require correction of electrolyte imbalances and provision of energy via intravenous therapy. - Hypokalemia: restores serum potassium levels in patients with low potassium. - Electrolyte replacement: supplies potassium ions as part of comprehensive electrolyte therapy. - Fluid and electrolyte replenishment: contributes to volume expansion and restores electrolyte balance during dehydration or surgery. - Energy supplementation in parenteral nutrition: provides glucose as an immediate energy source for patients receiving total parenteral nutrition.

Common Side Effects: - Mild vein irritation or phlebitis at the infusion site. - Transient hyperglycemia due to the glucose component. - Slight increase in serum potassium that may cause mild tingling. - Nausea or mild abdominal discomfort. - Localized swelling or edema.

Serious or Rare Side Effects: - Hyperkalemia leading to cardiac arrhythmias. - Severe allergic reaction or anaphylaxis. - Acute metabolic acidosis. - Severe hyperglycemia with osmotic diuresis. - Hemolysis if the solution is mixed with incompatible drugs.

Before administration, assess serum electrolyte levels and renal function. - Monitor: frequent checks of serum potassium and glucose during infusion. - Adjust infusion rate: tailor to patient’s clinical status and laboratory values. - Contraindications: avoid in patients with known hypersensitivity to potassium chloride or glucose. - Compatibility: do not mix with calcium-containing solutions or certain antibiotics without verification. - Store at ambient temperature: keep in original container, protect from light and moisture.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - ACE inhibitors or ARBs: may potentiate potassium accumulation. - Sodium bicarbonate infusion: can cause rapid shifts in potassium.

Moderate Interactions (Monitor Closely): - Insulin therapy: glucose may alter insulin requirements. - Beta‑agonists (e.g., albuterol): may cause transient potassium shifts. - Renal replacement therapies: adjust dosing based on clearance.